Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CISPLATIN vs CLARITHROMYCIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CISPLATIN vs CLARITHROMYCIN: Safety Overview

Metric CISPLATIN CLARITHROMYCIN
Total FAERS Reports 47,481 18,945
Deaths Reported 8,387 987
Death Rate 17.7% 5.2%
Hospitalizations 17,469 6,385
Average Patient Age 52.7 yrs 52.9 yrs
% Female Patients 40.0% 67.0%
FDA Approval Date Approved Prior to Jan 1, 1982 Apr 25, 2019
Manufacturer Apotex Corp. Asclemed USA, Inc.
Route INTRAVENOUS ORAL
Marketing Status Discontinued Discontinued